Search results

1705 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
"Heart Failure Management: Established Therapy and New Frontiers"
The Division of Cardiology Heart Failure Program will present this course from July 16-19 at the Amelia Conference Center in Amelia Island, Florida.
Located in Vital Signs / 2009 / April
$2.8-million NIH Funding for Interdisciplinary Team to study clotting risk in Atrial Fibrillation
Boyce Griffith, PhD, Associate Professor of Mathematics, member of the McAllister Heart Institute, and Adjunct Faculty in the Departments of Applied Physical Sciences and Biomedical Engineering, has received a $2.8-million award from the National Institutes of Health for a new 5-year project, Multiscale Modeling of Clotting Risk in Atrial Fibrillation. This is a multi-institutional project led by UNC but also involving Duke and the University of Utah. UNC co-investigators include John Vavalle, MD, Assistant Professor of Medicine in the Division of Cardiology.
Located in Vital Signs / 2018 / Oct. 4
$5.6 million NIH grant funds new UNC osteoarthritis research center
Arthritis affects 50 million people in the United States, with more than 27 million of those suffering the disabling pain of OA, a form of arthritis that causes joint swelling and degeneration.
Located in News / 2013 / August
'Good' bacteria is possible solution for unchecked inflammation in bowel diseases
In a study published in journal Nature Immunology, researchers led by UNC Lineberger member Jenny P.Y. Ting, PhD, describe how inflammation can go unchecked in the absence of a certain inflammation inhibitor called NLRP12. In a harmful feedback loop, this inflammation can upset the balance of bacteria living in the gut. Beneficial bacterial may be the key to reversing inflammation in the absence of this key regulator.
Located in News / 2017 / March
Dr. Neeta Vora is lead author on this new research on improving prenatal diagnosis. Exome sequencing can be done on fetal specimens to identify the genetic cause of structural abnormalities or disease by sequencing the coding regions of the genome, known as the exons. For this study, the research team performed exome sequencing using DNA from 15 fetuses with ultrasound detected abnormalities and their parents.
Located in Vital Signs / 2017 / June 8
'Smart' insulin could reduce dangerous complications of diabetes treatment
Researchers published a new study, supported by the North Carolina Translational and Clinical Sciences (NC TraCS) Institute, showing how a "smart" insulin patch could reduce dangerous complications in people who use the drug to manage diabetes.
Located in Vital Signs / 2019 / May 24
5-question clinical tool the first to help screen risk of violence in military veterans
Study highlights need to focus not only on PTSD for understanding violence in veterans
Located in News / 2014 / June
14th Annual Gottschalk Lecture - "Super-sized Hearts: Molecules and Mechanisms"
Please join us for this year's Carl W. Gottschalk Lecture. The guest speaker will be Christine Seidman, M.D. She is the T.W. Smith Professor of Medicine and Genetics & Director, Brigham & Women's Cardiovascular Genetics Center at Harvard Medical School.
Located in Vital Signs / 2010 / Vital Signs - Feb. 25, 2010
14th Annual Gottschalk Lecture - "Super-sized Hearts: Molecules and Mechanisms"
Please join us for this year's Carl W. Gottschalk Lecture. The guest speaker will be Christine Seidman, M.D. She is the T.W. Smith Professor of Medicine and Genetics & Director, Brigham & Women's Cardiovascular Genetics Center at Harvard Medical School.
Located in Vital Signs / Archives / Vital Signs - Feb. 25, 2010
24-week hepatitis C treatment as effective as 48-week treatment
A new study, conducted in part at UNC, finds that a 24-week triple medication treatment course for hepatitis C is just as effective as a 48-week regimen.
Located in News / 2011 / September